Literature DB >> 3265959

Cardiolipin antibodies and null alleles of C4 in black Americans with systemic lupus erythematosus.

W A Wilson1, M C Perez, J P Michalski, P E Armatis.   

Abstract

Twelve of 44 black American patients with systemic lupus erythematosus (SLE) (27%) studied during periods of disease activity had increased levels of IgG antibodies against cardiolipin (IgG aCL). IgG aCL occurred almost exclusively in patients who had a partial genetic deficiency of C4A or C4B. Eleven of 29 patients (38%) with a C4A or C4B deficiency allele had IgG aCL, compared with 1/15 patients (7%) who did not have C4A or C4B deficiency allele (p = 0.04). During periods when SLE was less active clinically, IgG aCL levels returned to normal in 10/12 patients. Active SLE, rather than null alleles, appeared to be associated with low C4 levels in patients with IgG aCL.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3265959

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

Review 1.  Ethnic and geographical variation in antiphospholipid (Hughes) syndrome.

Authors:  I Uthman; M Khamashta
Journal:  Ann Rheum Dis       Date:  2005-05-26       Impact factor: 19.103

2.  Homozygous complement factor deficiency and primary antiphospholipid syndrome: a clinical and serological study.

Authors:  M R Julià; N Matamoros; J Milà; X Bestard; J Gascó; A Morey; G Amer
Journal:  Ann Rheum Dis       Date:  1995-06       Impact factor: 19.103

Review 3.  The 'antiphospholipid syndrome' and the 'lupus anticoagulant'.

Authors:  J S Cameron; G Frampton
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

Review 4.  Complement activation and pregnancy failure.

Authors:  Angela Tincani; Ilaria Cavazzana; Tamara Ziglioli; Andrea Lojacono; Valentina De Angelis; Pierluigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2010-12       Impact factor: 8.667

Review 5.  Antiphospholipid syndrome: genetic review.

Authors:  Bahram Namjou
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

Review 6.  Pathophysiology of the antiphospholipid antibody syndrome.

Authors:  Rohan Willis; Silvia S Pierangeli
Journal:  Auto Immun Highlights       Date:  2011-03-24

7.  Pathogenic Role of Complement in Antiphospholipid Syndrome and Therapeutic Implications.

Authors:  Francesco Tedesco; Maria Orietta Borghi; Maria Gerosa; Cecilia Beatrice Chighizola; Paolo Macor; Paola Adele Lonati; Alessandro Gulino; Beatrice Belmonte; Pier Luigi Meroni
Journal:  Front Immunol       Date:  2018-06-19       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.